1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Coronary Stents Market
2.2. Global Coronary Stents Market, By Product, 2023 (US$ Million)
2.3. Global Coronary Stents Market, By Geography, 2023 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2023

3. Coronary Stents Market: Competitive Analysis
3.1. Market Positioning of Key Coronary Stents Market Vendors
3.2. Strategies Adopted by Coronary Stents Market Vendors
3.3. Key Industry Strategies
4. Coronary Stents Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Coronary Stents Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Coronary Stents Market: By Product, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Drug Eluting Stents
5.3.2. Bare Metal Stents
5.3.3. Bioresorbable Vascular Scaffolds


6. North America Coronary Stents Market, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Coronary Stents Market: By Product, 2022-2032, USD (Million)
6.3.Coronary Stents Market: By Region, 2022-2032, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)

7. UK and European Union Coronary Stents Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Coronary Stents Market: By Product, 2022-2032, USD (Million)
7.3.Coronary Stents Market: By Region, 2022-2032, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)
7.3.1.5. France
7.3.1.5.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)

8. Asia Pacific Coronary Stents Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Coronary Stents Market: By Product, 2022-2032, USD (Million)
8.3.Coronary Stents Market: By Region, 2022-2032, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)
8.3.1.3. India
8.3.1.3.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)

9. Latin America Coronary Stents Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Coronary Stents Market: By Product, 2022-2032, USD (Million)
9.3.Coronary Stents Market: By Region, 2022-2032, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)

10. Middle East and Africa Coronary Stents Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Coronary Stents Market: By Product, 2022-2032, USD (Million)
10.3.Coronary Stents Market: By Region, 2022-2032, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Coronary Stents Market: By Product, 2022-2032, USD (Million)

11. Company Profile
11.1. Abbott Laboratories, Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Amaranth Medical, Inc.
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Biotronik SE & Co. KG
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. B.Braun Melsungen AG
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Boston Scientific Corporation
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Cook Medical, Inc.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. C.R. Bard, Inc.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Johnson & Johnson
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Medtronic, Plc
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Microport Scientific Corporation
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives
11.11. Terumo Corporation
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Portfolio
11.11.4. Strategic Initiatives